Insider · CIK 0001969082

Cislini Jeff

Reports to the SEC for 1 company · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001969082

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-25	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−765 sh	$207.32	−$159K	51,776
2026-09-16	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−52 sh	$195.01	−$10.1K	55,855
2026-09-16	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−3,314 sh	$199.30	−$660K	52,541
2026-08-21	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−3,400 sh	$207.24	−$705K	109,401
2026-08-21	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−25.8K sh	$209.25	−$5.4M	66,261
2026-08-21	RVMDRevolution Medicines, Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+29.7K sh	$18.56	+$551K	86,201
2026-08-21	RVMDRevolution Medicines, Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+26.6K sh	$21.61	+$575K	112,801
2026-08-21	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−17.3K sh	$208.37	−$3.61M	92,078
2026-08-21	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−26.6K sh	—	—	3,500
2026-08-21	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−29.7K sh	—	—	0
2026-08-21	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−3,314 sh	$212.06	−$703K	55,907
2026-08-21	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−4,500 sh	$211.34	−$951K	59,221
2026-08-21	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−2,540 sh	$210.26	−$534K	63,721
2026-06-16	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−2,157 sh	$156.12	−$337K	56,521
2026-03-19	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−1,163 sh	$97.44	−$113K	58,518
2026-03-17	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−1,795 sh	$99.48	−$179K	59,681
2026-03-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	SVP & General Counsel	AAward	+32.5K sh	—	—	32,500
2026-03-01	RVMDRevolution Medicines, Inc.A Award	SVP & General Counsel	AAward	+14.5K sh	—	—	61,476
2026-01-21	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−908 sh	$115.60	−$105K	46,976
2025-12-16	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−2,688 sh	$76.82	−$206K	47,884
2025-11-18	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−13.4K sh	—	—	0
2025-11-18	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−13.4K sh	$70.14	−$939K	50,425
2025-11-18	RVMDRevolution Medicines, Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+13.4K sh	$42.45	+$568K	63,813
2025-10-17	RVMDRevolution Medicines, Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+12K sh	$36.57	+$439K	62,425
2025-10-17	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−12K sh	$55.00	−$660K	50,425
2025-10-17	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−12K sh	—	—	18,000
2025-09-24	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−1,799 sh	$44.26	−$79.6K	50,425
2025-09-16	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−1,869 sh	$45.82	−$85.6K	52,224
2025-06-20	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−1,912 sh	$39.61	−$75.7K	54,093
2025-06-16	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−1,878 sh	$39.83	−$74.8K	56,005
2025-03-20	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−2,041 sh	$38.71	−$79K	57,723
2025-03-17	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−1,458 sh	$39.04	−$56.9K	59,764
2025-03-01	RVMDRevolution Medicines, Inc.A Award	SVP & General Counsel	AAward	+22K sh	—	—	61,222
2025-03-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	SVP & General Counsel	AAward	+77K sh	—	—	77,000
2025-01-21	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−2,406 sh	$40.50	−$97.4K	39,222
2024-12-16	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−1,599 sh	$45.40	−$72.6K	41,628
2024-11-15	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−2,554 sh	$55.13	−$141K	43,080
2024-11-06	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−6,000 sh	$60.00	−$360K	45,634
2024-11-06	RVMDRevolution Medicines, Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+6,000 sh	$36.57	+$219K	51,634
2024-11-06	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−6,000 sh	—	—	30,000
2024-10-11	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	−6,000 sh	—	—	36,000
2024-10-11	RVMDRevolution Medicines, Inc.M Exercise/Conversion	SVP & General Counsel	MExercise/Conversion	+6,000 sh	$36.57	+$219K	51,634
2024-10-11	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−6,000 sh	$50.17	−$301K	45,634
2024-09-16	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−1,454 sh	$44.19	−$64.2K	45,634
2024-07-09	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−2,399 sh	$40.83	−$98K	47,088
2024-06-26	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−2,000 sh	$38.47	−$76.9K	49,487
2024-06-17	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−1,757 sh	$37.39	−$65.7K	51,487
2024-05-21	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−700 sh	$38.67	−$27.1K	53,674
2024-05-21	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−800 sh	$39.51	−$31.6K	52,874
2024-03-27	RVMDRevolution Medicines, Inc.S Sale	SVP & General Counsel	SSale	−800 sh	$31.52	−$25.2K	54,374

Recent filings

Accepted (ET)
Sep 294
Cislini Jeff0001969082-26-000011
SEC(opens sec.gov)
Sep 184
Cislini Jeff0001969082-26-000009
SEC(opens sec.gov)
Aug 254
Cislini Jeff0001610717-26-000388
SEC(opens sec.gov)
Jun 184
Cislini Jeff0001610717-26-000245
SEC(opens sec.gov)
Mar 194
Cislini Jeff0001610717-26-000127
SEC(opens sec.gov)
Mar 34
Cislini Jeff0001610717-26-000080
SEC(opens sec.gov)
Jan 234
Cislini Jeff0001610717-26-000018
SEC(opens sec.gov)
Dec 184
Cislini Jeff0001610717-25-000424
SEC(opens sec.gov)

Companies

Revolution Medicines, Inc.SVP & General CounselRVMD

Address

REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE

REDWOOD CITY, CA, 94063